Browsing by Author "Stojanovic, Miroslav (55442973200)"
Now showing 1 - 10 of 10
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Disability and quality of life in Guillain-Barré syndrome – Longitudinal study(2020) ;Berisavac, Ivana (6507392420) ;Arsenijevic, Mirjana (57357620400) ;Bozovic, Ivo (57194468421) ;Mladenovic, Branka (57216509488) ;Kacar, Aleksandra (6602386522) ;Stojiljkovic Tamas, Olivera (57202112475) ;Petrovic, Milutin (36969833200) ;Stojanovic, Miroslav (55442973200) ;Vujovic, Balsa (57021631300) ;Martic, Vesna (6602650915) ;Jovanovic, Dejana (55419203900) ;Lavrnic, Dragana (6602473221) ;Basta, Ivana (8274374200)Peric, Stojan (35750481700)Longitudinal health-related quality of life (QoL) data in Guillain-Barré (GBS) patients are still scarce. We, therefore, investigated health- related QoL in GBS patients from Serbia and surrounding countries during a six-month follow-up period, and analyzed its association with patients' disability. Our study comprised 74 adult patients diagnosed with GBS from May 2017 until May 2018 in seven tertiary healthcare centers. Health-related QoL was investigated using the SF-36 questionnaire, and compared with functional disability assessed by the GBS disability scale (GDS). Tests were performed at day 14, day 28, month 3 and month 6 from disease onset. GDS and SF-36 scores improved over time (p < 0.01). GDS scores were different at all four time points, while SF-36 did not differ between day 14 and day 28. Pooled SF-36 scores (especially physical ones) correlated with pooled GDS scores, except for Bodily Pain and Role Emotional scores. We found that GDS score at day 14 was an independent predictor of GDS score at month 6 (β = +0.52, p < 0.01), while SF-36 score at day 14 was an independent predictor of SF-36 score at month 6 (β = +0.51, p < 0.01). Neurologists should look not only on disability but also on QoL in GBS patients, since these two measures provide us with important complementary items of information. © 2020 Elsevier Ltd - Some of the metrics are blocked by yourconsent settings
Publication Disability and quality of life in Guillain-Barré syndrome – Longitudinal study(2020) ;Berisavac, Ivana (6507392420) ;Arsenijevic, Mirjana (57357620400) ;Bozovic, Ivo (57194468421) ;Mladenovic, Branka (57216509488) ;Kacar, Aleksandra (6602386522) ;Stojiljkovic Tamas, Olivera (57202112475) ;Petrovic, Milutin (36969833200) ;Stojanovic, Miroslav (55442973200) ;Vujovic, Balsa (57021631300) ;Martic, Vesna (6602650915) ;Jovanovic, Dejana (55419203900) ;Lavrnic, Dragana (6602473221) ;Basta, Ivana (8274374200)Peric, Stojan (35750481700)Longitudinal health-related quality of life (QoL) data in Guillain-Barré (GBS) patients are still scarce. We, therefore, investigated health- related QoL in GBS patients from Serbia and surrounding countries during a six-month follow-up period, and analyzed its association with patients' disability. Our study comprised 74 adult patients diagnosed with GBS from May 2017 until May 2018 in seven tertiary healthcare centers. Health-related QoL was investigated using the SF-36 questionnaire, and compared with functional disability assessed by the GBS disability scale (GDS). Tests were performed at day 14, day 28, month 3 and month 6 from disease onset. GDS and SF-36 scores improved over time (p < 0.01). GDS scores were different at all four time points, while SF-36 did not differ between day 14 and day 28. Pooled SF-36 scores (especially physical ones) correlated with pooled GDS scores, except for Bodily Pain and Role Emotional scores. We found that GDS score at day 14 was an independent predictor of GDS score at month 6 (β = +0.52, p < 0.01), while SF-36 score at day 14 was an independent predictor of SF-36 score at month 6 (β = +0.51, p < 0.01). Neurologists should look not only on disability but also on QoL in GBS patients, since these two measures provide us with important complementary items of information. © 2020 Elsevier Ltd - Some of the metrics are blocked by yourconsent settings
Publication Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy(2018) ;Bjelica, Bogdan (57194461405) ;Basta, Ivana (8274374200) ;Bozovic, Ivo (57194468421) ;Kacar, Aleksandra (6602386522) ;Nikolic, Ana (19933823000) ;Dominovic-Kovacevic, Aleksandra (37028225600) ;Vukojevic, Zoran (26025746700) ;Martic, Vesna (6602650915) ;Stojanov, Aleksandar (57194143903) ;Djordjevic, Gordana (35763715800) ;Petrovic, Milutin (36969833200) ;Stojanovic, Miroslav (55442973200)Peric, Stojan (35750481700)It has been previously shown that patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are unemployed or retired have worse quality of life. The aim of this study was to assess predictors of early retirement in CIDP. One hundred five patients with CIDP were included. Following measures were used: questionnaire on employment status, Medical Research Council Sum Score, INCAT disability score, Beck Depression Inventory, and Krupp's Fatigue Severity Scale. At the moment of testing, 2% of patients were students, 15% were employed, 9% were unemployed due to CIDP, 9% were unemployed but not due to CIDP, 28% were retired early due to disability caused by CIDP, and finally 37% were in old-age pension. Mean age when patients retired due to CIDP was 50 ± 8 years. Mean time from CIDP onset to retirement was 2.7 ± 2.3 years. Older age at onset, lower education, and more severe weakness at the time of diagnosis were significant predictors of early retirement due to CIDP. Retired patients were 12 times more likely to suffer from depression, compared to employed patients (OR = 12.2, 95% CI = 1.41-100, P < 0.01), and eight times more likely to have fatigue (OR = 8.2, 95% CI = 1.89-35.82, P < 0.01). Older patients with lower education and more severe weakness at the time of diagnosis were most likely retired due to CIDP. Early retirement was associated with depression and fatigue. Therefore, maintaining employment should be an important aim in the management of CIDP patients. © 2018 Peripheral Nerve Society - Some of the metrics are blocked by yourconsent settings
Publication Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy(2018) ;Bjelica, Bogdan (57194461405) ;Basta, Ivana (8274374200) ;Bozovic, Ivo (57194468421) ;Kacar, Aleksandra (6602386522) ;Nikolic, Ana (19933823000) ;Dominovic-Kovacevic, Aleksandra (37028225600) ;Vukojevic, Zoran (26025746700) ;Martic, Vesna (6602650915) ;Stojanov, Aleksandar (57194143903) ;Djordjevic, Gordana (35763715800) ;Petrovic, Milutin (36969833200) ;Stojanovic, Miroslav (55442973200)Peric, Stojan (35750481700)It has been previously shown that patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are unemployed or retired have worse quality of life. The aim of this study was to assess predictors of early retirement in CIDP. One hundred five patients with CIDP were included. Following measures were used: questionnaire on employment status, Medical Research Council Sum Score, INCAT disability score, Beck Depression Inventory, and Krupp's Fatigue Severity Scale. At the moment of testing, 2% of patients were students, 15% were employed, 9% were unemployed due to CIDP, 9% were unemployed but not due to CIDP, 28% were retired early due to disability caused by CIDP, and finally 37% were in old-age pension. Mean age when patients retired due to CIDP was 50 ± 8 years. Mean time from CIDP onset to retirement was 2.7 ± 2.3 years. Older age at onset, lower education, and more severe weakness at the time of diagnosis were significant predictors of early retirement due to CIDP. Retired patients were 12 times more likely to suffer from depression, compared to employed patients (OR = 12.2, 95% CI = 1.41-100, P < 0.01), and eight times more likely to have fatigue (OR = 8.2, 95% CI = 1.89-35.82, P < 0.01). Older patients with lower education and more severe weakness at the time of diagnosis were most likely retired due to CIDP. Early retirement was associated with depression and fatigue. Therefore, maintaining employment should be an important aim in the management of CIDP patients. © 2018 Peripheral Nerve Society - Some of the metrics are blocked by yourconsent settings
Publication Incidence and mortality rates of Guillain-Barré syndrome in Serbia(2020) ;Stojanov, Aleksandar (57194143903) ;Berisavac, Ivana (6507392420) ;Bozovic, Ivo (57194468421) ;Arsenijevic, Mirjana (57357620400) ;Lukic-Rajic, Sonja (56516616500) ;Petrovic, Milutin (36969833200) ;Stojiljkovic-Tamas, Olivera (57202112475) ;Jovin, Zita (8208650200) ;Djordjevic, Gordana (35763715800) ;Jovanovic, Dejana (55419203900) ;Stojanovic, Miroslav (55442973200) ;Martic, Vesna (6602650915) ;Basta, Ivana (8274374200)Peric, Stojan (35750481700)Guillain-Barré syndrome (GBS) is an acute auto-immune polyradiculoneuropathy. A huge variety of GBS incidence and mortality rates has been noted across the world. The objective of the present multi-centric study was to assess the incidence and mortality rates of GBS during a 10-year period in Serbia. We collected data of adult GBS patients who were hospitalized from 2009 to 2018 in all five tertiary healthcare centers in Serbia. The incidence rates per 100 000 inhabitants with 95% confidence intervals (CI) were calculated and further corrected for the estimated number of patients hospitalized in secondary centers. Mortality rates were also assessed. GBS was considered severe if patients were not able to walk at least 10 m without assistance. Six hundred and forty GBS patients were registered in tertiary centers in a 10-year period. The proportion of severe cases was 75% at nadir, and 52% on discharge. GBS incidence rate in Serbia was 1.1 per 100 000 inhabitants, and estimated incidence if patients from secondary centers included 1.2 per 100 000. Peak incidence was observed during the sixth decade of life. During the acute phase, 5.6% of GBS patients died, while overall 9.7% of them died during 6-month period from disease onset. This study contributes to our knowledge about GBS epidemiology. Results will allow us to improve the diagnosis and treatment of GBS patients in Serbia. © 2020 Peripheral Nerve Society. - Some of the metrics are blocked by yourconsent settings
Publication Incidence and mortality rates of Guillain-Barré syndrome in Serbia(2020) ;Stojanov, Aleksandar (57194143903) ;Berisavac, Ivana (6507392420) ;Bozovic, Ivo (57194468421) ;Arsenijevic, Mirjana (57357620400) ;Lukic-Rajic, Sonja (56516616500) ;Petrovic, Milutin (36969833200) ;Stojiljkovic-Tamas, Olivera (57202112475) ;Jovin, Zita (8208650200) ;Djordjevic, Gordana (35763715800) ;Jovanovic, Dejana (55419203900) ;Stojanovic, Miroslav (55442973200) ;Martic, Vesna (6602650915) ;Basta, Ivana (8274374200)Peric, Stojan (35750481700)Guillain-Barré syndrome (GBS) is an acute auto-immune polyradiculoneuropathy. A huge variety of GBS incidence and mortality rates has been noted across the world. The objective of the present multi-centric study was to assess the incidence and mortality rates of GBS during a 10-year period in Serbia. We collected data of adult GBS patients who were hospitalized from 2009 to 2018 in all five tertiary healthcare centers in Serbia. The incidence rates per 100 000 inhabitants with 95% confidence intervals (CI) were calculated and further corrected for the estimated number of patients hospitalized in secondary centers. Mortality rates were also assessed. GBS was considered severe if patients were not able to walk at least 10 m without assistance. Six hundred and forty GBS patients were registered in tertiary centers in a 10-year period. The proportion of severe cases was 75% at nadir, and 52% on discharge. GBS incidence rate in Serbia was 1.1 per 100 000 inhabitants, and estimated incidence if patients from secondary centers included 1.2 per 100 000. Peak incidence was observed during the sixth decade of life. During the acute phase, 5.6% of GBS patients died, while overall 9.7% of them died during 6-month period from disease onset. This study contributes to our knowledge about GBS epidemiology. Results will allow us to improve the diagnosis and treatment of GBS patients in Serbia. © 2020 Peripheral Nerve Society. - Some of the metrics are blocked by yourconsent settings
Publication Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy(2018) ;Kacar, Aleksandra (6602386522) ;Bjelica, Bogdan (57194461405) ;Bozovic, Ivo (57194468421) ;Peric, Stojan (35750481700) ;Nikolic, Ana (19933823000) ;Cobeljic, Mina (57196349878) ;Petrovic, Milutin (36969833200) ;Stojanov, Aleksandar (57194143903) ;Djordjevic, Gordana (35763715800) ;Vukojevic, Zoran (26025746700) ;Dominovic-Kovacevic, Aleksandra (37028225600) ;Stojanovic, Miroslav (55442973200) ;Stevic, Zorica (57204495472) ;Rakocevic-Stojanovic, Vidosava (6603893359) ;Lavrnic, Dragana (6602473221)Basta, Ivana (8274374200)To date, generic questionnaires have been used to investigate quality of life (QoL) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients. Although these measures are very useful, they are not usually precise enough to measure all specific characteristics of the disease. Our aim was to investigate QoL using the neuromuscular disease-specific questionnaire (individualized neuromuscular quality of life, INQoL) in a large cohort of patients with CIDP. Our study comprised 106 patients diagnosed with CIDP. INQoL questionnaire, Medical Research Council (MRC) sum score, Inflammatory Neuropathy Cause and Treatment (INCAT) disability score, Visual Analogue Pain Scale, Beck Depression Inventory, and Krupp's Fatigue Severity Scale were used in our study. Physical domains of INQoL were more affected than mental, and the overall score was 57 ± 25. Significant predictors of higher INQoL score in our patients with CIDP were severe fatigue (β = 0.35, p < 0.01), higher INCAT disability score at time of testing (β = 0.29, p < 0.01), and being unemployed/retired (β = 0.22, p < 0.05). QoL was reduced in our cohort of CIDP patients, which was more pronounced in physical segments. Patients with fatigue, more severe disability, and unemployed/retired need special attention of neurologists because they could be at greater risk to have worse QoL. © 2018 Peripheral Nerve Society - Some of the metrics are blocked by yourconsent settings
Publication Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy(2018) ;Kacar, Aleksandra (6602386522) ;Bjelica, Bogdan (57194461405) ;Bozovic, Ivo (57194468421) ;Peric, Stojan (35750481700) ;Nikolic, Ana (19933823000) ;Cobeljic, Mina (57196349878) ;Petrovic, Milutin (36969833200) ;Stojanov, Aleksandar (57194143903) ;Djordjevic, Gordana (35763715800) ;Vukojevic, Zoran (26025746700) ;Dominovic-Kovacevic, Aleksandra (37028225600) ;Stojanovic, Miroslav (55442973200) ;Stevic, Zorica (57204495472) ;Rakocevic-Stojanovic, Vidosava (6603893359) ;Lavrnic, Dragana (6602473221)Basta, Ivana (8274374200)To date, generic questionnaires have been used to investigate quality of life (QoL) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients. Although these measures are very useful, they are not usually precise enough to measure all specific characteristics of the disease. Our aim was to investigate QoL using the neuromuscular disease-specific questionnaire (individualized neuromuscular quality of life, INQoL) in a large cohort of patients with CIDP. Our study comprised 106 patients diagnosed with CIDP. INQoL questionnaire, Medical Research Council (MRC) sum score, Inflammatory Neuropathy Cause and Treatment (INCAT) disability score, Visual Analogue Pain Scale, Beck Depression Inventory, and Krupp's Fatigue Severity Scale were used in our study. Physical domains of INQoL were more affected than mental, and the overall score was 57 ± 25. Significant predictors of higher INQoL score in our patients with CIDP were severe fatigue (β = 0.35, p < 0.01), higher INCAT disability score at time of testing (β = 0.29, p < 0.01), and being unemployed/retired (β = 0.22, p < 0.05). QoL was reduced in our cohort of CIDP patients, which was more pronounced in physical segments. Patients with fatigue, more severe disability, and unemployed/retired need special attention of neurologists because they could be at greater risk to have worse QoL. © 2018 Peripheral Nerve Society - Some of the metrics are blocked by yourconsent settings
Publication Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy(2017) ;Bozovic, Ivo (57194468421) ;Kacar, Aleksandra (6602386522) ;Peric, Stojan (35750481700) ;Nikolic, Ana (19933823000) ;Bjelica, Bogdan (57194461405) ;Cobeljic, Mina (57196349878) ;Petrovic, Milutin (36969833200) ;Stojanov, Aleksandar (57194143903) ;Djuric, Vanja (35361619800) ;Stojanovic, Miroslav (55442973200) ;Djordjevic, Gordana (35763715800) ;Martic, Vesna (6602650915) ;Dominovic, Aleksandra (56516864600) ;Vukojevic, Zoran (26025746700)Basta, Ivana (8274374200)Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic disease which can lead to many functional impairments, and like most other chronic disorders it might significantly affect quality of life (QoL). Information about QoL in patients with CIDP from developing countries is still lacking. We, therefore, sought to complete these data mosaic by investigating QoL in patients with CIDP from Serbia and surrounding countries. Our study comprised 106 patients diagnosed with CIDP. QoL was investigated using the Serbian version of the SF-36 questionnaire. The Medical Research Council 0–5 point scale, INCAT motor and sensory scores, Krupp’s Fatigue Severity Scale, and Beck Depression Inventory were also used. Factors that significantly correlated with SF-36 total score in univariate analysis were included in the multiple linear regression analysis. Physical domains of the SF-36 were more affected than mental, and the overall score was 56.6 ± 25.4. Significant predictors of worse SF-36 score in our patients with CIDP were severe fatigue (β = − 0.331, p < 0.01), higher INCAT motor score (β = − 0.301, p < 0.01), depression (β = − 0.281, p < 0.01), being unemployed/retired (β = − 0.188, p < 0.05), and shorter duration of CIDP (β = + 0.133, p < 0.01). QoL was reduced in CIDP patients, especially in physical domains. Patients with presence of fatigue and depression, with more severe motor disability, unemployed/retired ones, and those with shorter duration of the disease need special attention of clinicians since they could be at higher risk to have worse QoL. © 2017, Springer-Verlag GmbH Germany. - Some of the metrics are blocked by yourconsent settings
Publication Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy(2017) ;Bozovic, Ivo (57194468421) ;Kacar, Aleksandra (6602386522) ;Peric, Stojan (35750481700) ;Nikolic, Ana (19933823000) ;Bjelica, Bogdan (57194461405) ;Cobeljic, Mina (57196349878) ;Petrovic, Milutin (36969833200) ;Stojanov, Aleksandar (57194143903) ;Djuric, Vanja (35361619800) ;Stojanovic, Miroslav (55442973200) ;Djordjevic, Gordana (35763715800) ;Martic, Vesna (6602650915) ;Dominovic, Aleksandra (56516864600) ;Vukojevic, Zoran (26025746700)Basta, Ivana (8274374200)Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic disease which can lead to many functional impairments, and like most other chronic disorders it might significantly affect quality of life (QoL). Information about QoL in patients with CIDP from developing countries is still lacking. We, therefore, sought to complete these data mosaic by investigating QoL in patients with CIDP from Serbia and surrounding countries. Our study comprised 106 patients diagnosed with CIDP. QoL was investigated using the Serbian version of the SF-36 questionnaire. The Medical Research Council 0–5 point scale, INCAT motor and sensory scores, Krupp’s Fatigue Severity Scale, and Beck Depression Inventory were also used. Factors that significantly correlated with SF-36 total score in univariate analysis were included in the multiple linear regression analysis. Physical domains of the SF-36 were more affected than mental, and the overall score was 56.6 ± 25.4. Significant predictors of worse SF-36 score in our patients with CIDP were severe fatigue (β = − 0.331, p < 0.01), higher INCAT motor score (β = − 0.301, p < 0.01), depression (β = − 0.281, p < 0.01), being unemployed/retired (β = − 0.188, p < 0.05), and shorter duration of CIDP (β = + 0.133, p < 0.01). QoL was reduced in CIDP patients, especially in physical domains. Patients with presence of fatigue and depression, with more severe motor disability, unemployed/retired ones, and those with shorter duration of the disease need special attention of clinicians since they could be at higher risk to have worse QoL. © 2017, Springer-Verlag GmbH Germany.
